Page last updated: 2024-12-11
lead-207
Cross-References
Synonyms (8)
| Synonym |
|---|
| lead-207 |
| (207)pb |
| CHEBI:52455 |
| (207)82pb |
| lead, isotope of mass 207 |
| 207pb |
| 14119-29-0 |
| DTXSID00161589 |
Research Excerpts
Compound-Compound Interactions
| Excerpt | Reference | Relevance |
|---|
| "Multivariate stable isotope analysis combined with chemometrics was used to investigate and discriminate rice samples from six rice producing provinces in China (Heilongjiang, Jilin, Jiangsu, Zhejiang, Hunan and Guizhou) and four other Asian rice producing countries (Thailand, Malaysia, Philippines, and Pakistan)." | ( Tracing the geographical origin of rice by stable isotopic analyses combined with chemometrics.
Chen, A; Chen, T; Wang, J; Yang, S; Zhang, W; Zhao, Y, 2020) | 0.56 |
Drug Classes (1)
| Class | Description |
|---|
| lead(0) | |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (6)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 29.75
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| Metric | This Compound (vs All) |
|---|
| Research Demand Index | 29.75 (24.57) | | Research Supply Index | 1.95 (2.92) | | Research Growth Index | 4.51 (4.65) | | Search Engine Demand Index | 34.37 (26.88) | | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |